Physicians Predict COURAGE Will Reduce U.S. Stent Procedures About 5%
This article was originally published in The Gray Sheet
Executive Summary
The highly publicized COURAGE trial will cause a roughly 5% reduction in the number of stent procedures in the United States, according to Dartmouth Medical School's Aaron Kaplan, M.D., and Carl Szot, M.D